Daptomycin
Sold as Cubicin, Drymred, Cusyn, Cubact, Daptomycin cipla, Reldaptos, Daptomycin equity, Dapicub, Xelodapto, Gapobak, Daptomycin hetero, Daptomycin accord
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 10
- Registrations
- 15
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Msd (Pty) LtdCancelled | Cubicin | Not stated | 430954 | S4 | None |
| Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr. Reddy’s Laboratories (Pty) Ltd. | Drymred | 500 mg | 510734 | S4 | PI |
| Pharma Dynamics (Pty) Ltd | Cusyn | 500 mg | 530432 | S4 | PIPIL |
| Macleods Pharmaceuticals SA (Pty) LtdCertificate held by Abex Pharmaceutica (Pty) Ltd | Cubact | 500 mg | 530433.432 | S4 | PIPIL |
| Cipla Medpro (Pty) Ltd | Daptomycin cipla, Reldaptos | 500 | 540554, 540555.554 | S4 | None |
| Equity Pharmaceutical (Pty) LtdCertificate held by Equity Pharmaceuticals (Pty) Ltd | Daptomycin equity | 500 mg | 540841 | S4 | PIPIL |
| Juno Pharma SA (Pty) LtdCertificate held by Kahma Biotech (Pty) Ltd | Dapicub | 500 mg | 550096 | S4 | PIPIL |
| Pharmaco Distribution (Pty) Ltd | Xelodapto | 500 | 561041 | S4 | None |
| Hetero Drugs South Africa (Pty) Ltd | Gapobak, Daptomycin hetero | 350 mg, 500 mg | 570159, 570160, 570161.159, 570162.160 | S4 | None |
| Accord Healthcare (Pty) Ltd | Daptomycin accord | 350, 500 | 580093, 580094 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cubicin EACH VIAL CONTAINS DAPTOMYCIN 500,0 mg | Not listed | 43095443/20.1/0954 | Cancelled | S4 | None |
| Drymred 500 EACH VIAL CONTAINS :DAPTOMYCIN 500,0 mg | 500 mg(Lyophilized powder for iv infusion | 51073451/20.1/0734Approved 25 March 2019 | Registered | S4 | PI |
| Cusyn DAPTOMYCIN | 500 mgPowder for solution for infusion | 53043253/20.1.1/0432Approved 23 October 2025 | Registered | S4 | PIPIL |
| Cubact DAPTOMYCIN | 500 mgPowder for solution for infusion | 530433.43253/20.1.1/0433Approved 30 May 2023 | Registered | S4 | PIPIL |
| Daptomycin cipla 500 EACH VIAL CONTAINS DAPTOMYCIN 500,0 mg | 500 | 54055454/20.1.1/0554 | Registered | S4 | None |
| Reldaptos 500 EACH VIAL CONTAINS DAPTOMYCIN 500,0 mg | 500 | 540555.55454/20.1.1/0555.554 | Registered | S4 | None |
| Daptomycin equity EACH VIAL CONTAINS DAPTOMYCIN 500,0 mg | 500 mgPowder for solution for infusion | 54084154/20.1/0841Approved 24 March 2023 | Registered | S4 | PIPIL |
| Dapicub EACH VIAL CONTAINS DAPTOMYCIN 500,0 mg | 500 mgPowder for solution for infusion | 55009655/20.1/0096Approved 14 March 2023 | Registered | S4 | PIPIL |
| Xelodapto 500 EACH VIAL CONTAINS DAPTOMYCIN 500,0 mg | 500 | 56104156/20.1/1041 | Registered | S4 | None |
| Gapobak 350 MG Each Vial contains: Daptomycin 350,0 mg | 350 mg | 57015957/20.1/0159 | Registered | S4 | None |
| Gapobak 500 MG Each Vial contains: Daptomycin 500,0 mg | 500 mg | 57016057/20.1/0160 | Registered | S4 | None |
| Daptomycin 350 hetero Each Vial contains: Daptomycin 350,0 mg | 350 | 570161.15957/20.1/0161.159 | Registered | S4 | None |
| Daptomycin 500 hetero Each Vial contains: Daptomycin 500,0 mg | 500 | 570162.16057/20.1/0162.160 | Registered | S4 | None |
| Daptomycin 350 accord EACH VIAL CONTAINS: DAPTOMYCIN 350,0 mg | 350 | 58009358/20.1.1/0093 | Registered | S4 | None |
| Daptomycin 500 accord EACH VIAL CONTAINS: DAPTOMYCIN 500,0 mg | 500 | 58009458/20.1.1/0094 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Daptomycin
S4: Daptomycin
Consolidated Schedules 06 July 2026, line 5948
Pharmacological class: Antibiotics and antibiotic combinations. (class 20.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.